Protocol ID93-008 
Page 19 
35. Kasid A. Morecki S. Aebersold P. et al. Human gene transfer; Characterization of human 
tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man Proc 
NatLAcadSci, 87:473-477, 1990. 
36. Morecki S, Karson E, Cometta K, et al. Retrovirus-mediated gene transfer into CD4+ and 
CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood 
mononuclear cells. Cancer Immunol Immunother 32:342-352, 1991. 
37. Rosenberg SA, Aebersold P, Cometta K, et al. Gene transfer into humans - immunotherapy 
of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by 
retroviral gene transduction. NEngJ Med 323:570-578, 1990. 
38. Anderson WF. Human Gene Therapy. Science 256:808-813, 1992. 
39. Miller AD. Human gene therapy comes of age. Nature 3576:455-460, 1992. 
40. Alexander RB, and Rosenberg SA. Adoptively transferred tumor-infiltrating lymphocytes can 
cure established metastatic tumor in mice and persist long-term in vivo as functional memory 
T lymphocytes. J/mmunother 10:389-397, 1991. 
41. Gunter KC, Khan AS, Noguchi PD. The safety of retroviral vectors. Human Gene Therapy 
4:643-645, 1993. 
42. Kotanl H, Newton PB, Zhang S, et al. Improved methods of retroviral vector transduction and 
production for gene therapy. Human Gene Therapy 5: 19-28, 1994. 
43. Morgan RA Cometta K, and Anderson WF. Applications of the polymerase chain reaction in 
retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells. Human 
Gene Therapy 1:135-149, 1990. 
44. Freedman RS, loannides CG, Tomasovic B, Patenia R, Zhang H-Z, Liang JC, and Edwards 
CL. Development of a cell surface reacting human monoclonal antibody recognizing ovarian 
and certain other malignancies. Hybridoma 10:21-33, 1991. 
[ 
Recombinant DNA Research, Volume 19 
[477] 
